If side effects are unmanageable, weight loss has stalled , or you are considering a formulation change, communicate with your provider
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
Estrogen fluctuations can influence GLP-1 sensitivity, potentially requiring dose adjustments over time
Who may benefit most from tirzepatide levocarnitine Not everyone on tirzepatide needs levocarnitine
Semaglutide can help reduce visceral fat, including stubborn belly fat, by supporting appetite control, improving insulin sensitivity, and encouraging fat loss rather than muscle loss
Address correspondence to: Ildiko Lingvay, MD, MPH, MSCS, 5323 Harry Hines Blvd, Dallas, TX 75390